Form 8-K - Current report:
SEC Accession No. 0001104659-23-028734
Filing Date
2023-03-06
Accepted
2023-03-06 06:34:59
Documents
57
Period of Report
2023-03-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm238549d1_8k.htm   iXBRL 8-K 66425
2 EXHIBIT 2.1 tm238549d1_ex2-1.htm EX-2.1 927876
3 EXHIBIT 10.1 tm238549d1_ex10-1.htm EX-10.1 36475
4 EXHIBIT 10.2 tm238549d1_ex10-2.htm EX-10.2 36573
5 EXHIBIT 99.1 tm238549d1_ex99-1.htm EX-99.1 66660
6 EXHIBIT 99.2 tm238549d1_ex99-2.htm EX-99.2 48987
7 EXHIBIT 99.3 tm238549d1_ex99-3.htm EX-99.3 86121
8 EXHIBIT 99.4 tm238549d1_ex99-4.htm EX-99.4 22747
12 GRAPHIC tm238549d1_ex99-1img01.jpg GRAPHIC 15465
13 GRAPHIC tm238549d1_ex99-1img02.jpg GRAPHIC 69673
14 GRAPHIC tm238549d1_ex99-2img001.jpg GRAPHIC 873379
15 GRAPHIC tm238549d1_ex99-2img002.jpg GRAPHIC 1197882
16 GRAPHIC tm238549d1_ex99-2img003.jpg GRAPHIC 873379
17 GRAPHIC tm238549d1_ex99-2img004.jpg GRAPHIC 392386
18 GRAPHIC tm238549d1_ex99-2img005.jpg GRAPHIC 436594
19 GRAPHIC tm238549d1_ex99-2img006.jpg GRAPHIC 394956
20 GRAPHIC tm238549d1_ex99-2img007.jpg GRAPHIC 339103
21 GRAPHIC tm238549d1_ex99-2img008.jpg GRAPHIC 330862
22 GRAPHIC tm238549d1_ex99-2img009.jpg GRAPHIC 454619
23 GRAPHIC tm238549d1_ex99-2img010.jpg GRAPHIC 357939
24 GRAPHIC tm238549d1_ex99-2img011.jpg GRAPHIC 461426
25 GRAPHIC tm238549d1_ex99-2img012.jpg GRAPHIC 415805
26 GRAPHIC tm238549d1_ex99-2img013.jpg GRAPHIC 301233
27 GRAPHIC tm238549d1_ex99-2img014.jpg GRAPHIC 367863
28 GRAPHIC tm238549d1_ex99-2img015.jpg GRAPHIC 253008
29 GRAPHIC tm238549d1_ex99-2img016.jpg GRAPHIC 436772
30 GRAPHIC tm238549d1_ex99-2img017.jpg GRAPHIC 49883
31 GRAPHIC tm238549d1_ex99-2img018.jpg GRAPHIC 492070
32 GRAPHIC tm238549d1_ex99-2img019.jpg GRAPHIC 589046
33 GRAPHIC tm238549d1_ex99-2img020.jpg GRAPHIC 444494
34 GRAPHIC tm238549d1_ex99-2img021.jpg GRAPHIC 379996
35 GRAPHIC tm238549d1_ex99-2img022.jpg GRAPHIC 228529
36 GRAPHIC tm238549d1_ex99-2img023.jpg GRAPHIC 406397
37 GRAPHIC tm238549d1_ex99-2img024.jpg GRAPHIC 442167
38 GRAPHIC tm238549d1_ex99-2img025.jpg GRAPHIC 321652
39 GRAPHIC tm238549d1_ex99-2img026.jpg GRAPHIC 333412
40 GRAPHIC tm238549d1_ex99-2img027.jpg GRAPHIC 381959
41 GRAPHIC tm238549d1_ex99-2img028.jpg GRAPHIC 387570
42 GRAPHIC tm238549d1_ex99-2img029.jpg GRAPHIC 300329
43 GRAPHIC tm238549d1_ex99-2img030.jpg GRAPHIC 537627
44 GRAPHIC tm238549d1_ex99-2img031.jpg GRAPHIC 412570
45 GRAPHIC tm238549d1_ex99-2img032.jpg GRAPHIC 356446
46 GRAPHIC tm238549d1_ex99-2img033.jpg GRAPHIC 349493
47 GRAPHIC tm238549d1_ex99-2img034.jpg GRAPHIC 493045
48 GRAPHIC tm238549d1_ex99-2img035.jpg GRAPHIC 342030
49 GRAPHIC tm238549d1_ex99-2img036.jpg GRAPHIC 338624
  Complete submission text file 0001104659-23-028734.txt   23138081

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA adap-20230305.xsd EX-101.SCH 3042
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE adap-20230305_lab.xml EX-101.LAB 34476
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adap-20230305_pre.xml EX-101.PRE 22601
51 EXTRACTED XBRL INSTANCE DOCUMENT tm238549d1_8k_htm.xml XML 3685
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 23707490
SIC: 2836 Biological Products, (No Diagnostic Substances)